Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant

Clinical trial NCT04908735 · TERMINATED

Trial details

NCT number: NCT04908735
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic Stem Cell Transplant (HSCT)Bronchiolitis Obliterans (BO)

Start date: 2021-11-12
Primary completion: 2025-09-17
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.